Posts from ‘December, 2009’

Premier Purchasing Partners Will Continue to Contract Jarit(R) Surgical and Laparoscopic Instruments PLAINSBORO, N.J., Dec. 21, 2009 (HSMN NewsFeed) — Integra LifeSciences Holdings Corporation (Nasdaq:IART ) announced today that it has signed a new thr…
Devices, Group Purchasing
Integra LifeSciences, Premier Purchasing, Jarit, Omni-Tract, Luxtec

Investment to Enable Advancement of Therapeutic and Commercial Aims IRVINE, Calif.–(HSMN NewsFeed)–California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The fi…
Regenerative Medicine, Venture Capital
California Stem Cell, MOTORGRAFT, stem cell, Spinal Muscular Atrophy

LUNESTA patent term extended by 760 days to February 14, 2014 FDA lifts medical hold on LUNESTA pediatric studies MARLBOROUGH, Mass.–(HSMN NewsFeed)–Sepracor Inc. today announced that the United States Patent and Trademark Office has determined th…
Biopharmaceuticals, FDA
Sepracor, LUNESTA, eszopiclone

Acquisition Creates Global Scale and Offers Revenues and Cost Synergies, Complements Alphatec Spine’s Product Portfolio and Enhances Aging Spine Focus Combined Entity to be Third-Largest Global Pure-Play Spinal Implant Company CARLSBAD, Calif., Dec. 17,…
Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions
Alphatec Spine, Scient’x, spine surgery

First Once-Daily Steroid-Free Maintenance Treatment That Has Been Shown to Reduce Exacerbations for People with COPD RIDGEFIELD, Conn. & NEW YORK–(HSMN NewsFeed)–Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced today that the U.S. …
Biopharmaceuticals, Drug Delivery, FDA
Pfizer, Boehringer Ingelheim, SPIRIVA, HandiHaler, tiotropium bromide, COPD

CARMIEL, Israel, Dec. 17 (HSMN NewsFeed) — Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) today announced the appointment of Sandra Lauterbach to Vice President, Revenue and Commercial Affairs. In this newly created, U.S. based job, Ms. Lauterbach …
Biopharmaceuticals, Personnel
Protalix BioTherapeutics

HUNTINGTON BEACH, California and AMSTERDAM, December 17 (HSMN NewsFeed) — Agendia, a world leader in molecular cancer diagnostics, announced today that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for al…
Diagnostics, Oncology, FDA
Agendia, MammaPrint

Acclarent’s Broad Product Portfolio Provides New Growth Platform in ENT SOMERVILLE, N.J., Dec. 16 (HSMN NewsFeed) — Ethicon, Inc., a Johnson & Johnson (NYSE: JNJ) company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held …
Devices, Mergers & Acquisitions
Ethicon, Johnson & Johnson, Acclarent

BOTHELL, Wash., Dec. 16 (HSMN NewsFeed) — Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-As…
Devices, Urology
Verathon, BladderScan, Urinary Tract Infection

IRVING, Texas, and PHOENIX, Dec. 16, 2009 –(HSMN NewsFeed) — Caris Diagnostics ("Caris Dx") - a big provider of integrated anatomic clinical laboratory and oncology testing services, including molecular profiling and hematopathology, announced that P…
Diagnostics, Personnel
Caris Diagnostics